![Cheryl Gault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cheryl Gault
Direttore operativo presso
RAPPORT THERAPEUTICS, INC.
Patrimonio netto: 6 M $ in data 31/07/2026
Profilo
Cheryl Gault is currently Chief Operating Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Ms. Gault was Chief Operating Officer at Cyclerion Therapeutics, Inc. from 2021 to 2023, VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. from 2017 to 2019, and held the position Head-Sales & Marketing at Genzyme Corp.
Ms. Gault completed undergraduate education at Boston College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2026 | 149.914 ( 0,31% ) | 6 M $ | 31/07/2026 |
Posizioni attive di Cheryl Gault
| Società | Posizione | Inizio |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Direttore operativo | 07/09/2023 |
Precedenti posizioni note di Cheryl Gault
| Società | Posizione | Fine |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direttore operativo | 28/07/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Vendite & Marketing | - |
Formazione di Cheryl Gault
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
